(Q40836955)

24 September 2017

Serum-associated inhibition of leukotaxis in humans with cancer (English)

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

28 March 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338223

28 March 2023

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

28 March 2023

3

Ward PA

1 reference

24 September 2017

E. G. Maderazo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338223

28 March 2023

T. F. Anton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A338223

28 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=338223

28 March 2023

publication date

1 February 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:0090122978900685?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

https://api.elsevier.com/content/article/PII:0090122978900685?httpAccept=text/plain

28 March 2023

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

Clinical Immunology and Immunopathology

28 March 2023

published in

1 reference

24 September 2017

9

1 reference

24 September 2017

166-176

1 reference

24 September 2017

2

1 reference

DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS

24 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

Defective regulation of inflammatory mediators in Hodgkin's disease. Supernormal levels of chemotactic-factor inactivator

28 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

Antileukotactic properties of tumor cells

28 March 2023

8

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator

28 March 2023

12

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

Editorial: How lymphocytes kill tumor cells

28 March 2023

18

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

The requirement of serine esterase function in complement-dependent erythrophagocytosis

28 March 2023

20

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

Leukotactic dystunction in sarcoidosis

28 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0090-1229(78)90068-5

28 March 2023

Identifiers

1 reference

24 September 2017

1 reference